{
Gilmore O’Neill

People

}
001122334455554433221100
001122334455554433221100

editas medicine lays off staff and shifts focus to in vivo gene editing

Editas Medicine will lay off 180 employees, about two-thirds of its workforce, as it shifts focus to “in vivo” gene editing after failing to find a partner for its sickle cell therapy. The company is ending development of its lead CRISPR medicine and will share more preclinical data in early 2025.
BioPharma Dive
United States Dollar bluebird bio, Inc. CRISPR Therapeutics AG Editas Medicine, Inc. Baisong Mei Gilmore O’Neill Show more
Technology & Innovation, News Article
01:00 12.12.2024

editas seeks partner for gene editing therapy amid strategic shift

Editas Medicine is seeking a partner or considering out-licensing its lead gene editing therapy, reni-cel, aimed at treating sickle cell disease and beta thalassemia. This shift comes as the company pivots from previous strategies and aims to reduce spending while advancing its research. Despite promising preclinical data, Editas faces challenges in bringing reni-cel to market, prompting a focus on in vivo gene editing for future treatments.
BioPharma Dive
United States Dollar Moelis & Company Vertex Pharmaceuticals Incorporated Genevant Sciences CRISPR Therapeutics AG Editas Medicine, Inc. USA Gilmore O’Neill Dae Gon Ha Show more
Healthcare, News Article
17:15 22.10.2024
Trending
Subcategory
Stock Market Updates Corporate News Industry Trends Finance Mergers & Acquisitions Hedge Funds & Private Equity Global Trade Developments Global Financial Events Market Analysis and Predictions Financial Scams and Security Government Policies Banking Regulations CEO Changes Economic Sanctions Startups & Entrepreneurship Retail and Consumer Goods Industry Mergers & Acquisitions Workplace Trends International Relations Central Bank Actions Government Economic Policies
Countries:
USA CHN IND GBR JPN CAN ARE DEU TWN ITA PRT EGY SGP BEL KOR CHE VNM JOR IDN IRN
Companies:
JPMorgan Chase & Co. Tesla, Inc. The Goldman Sachs Group, Inc. Wells Fargo & Company Bank of America Corporation Barclays PLC Apple Inc. Citigroup Inc. Morgan Stanley Berkshire Hathaway Inc. Microsoft Corporation SpaceXCoin USD The Charles Schwab Corporation AMERICAN EXPRESS Amazon.com, Inc. U.S. Bancorp UBS Group AG Banco Santander, S.A. Deutsche Bank Money Market PP Citizens, Inc.
Currencies:
United States Dollar Euro Indian Rupee Chinese Yuan Japanese Yen British Pound Sterling South Korean Won Swiss Franc United Arab Emirates Dirham Canadian Dollar Israeli New Shekel Swedish Krona Mexican Peso New Taiwan Dollar Egyptian Pound
People:
Donald Trump Elon Musk Warren Buffett Jerome Powell Matteo Salvini Sara Wechter Troy L Rohrbaugh Stacey Friedman Robin Leopold Peter Navarro James L Chosy Michael Feroli Mark Mason Jeff Bezos Mark Zuckerberg Tom Scholar Joe Biden Anand Selvakesari Andrew Cecere Terrance R. Dolan

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.